Invitae Corp NVTA

NVTA Quotes by TradingView
Institutional shares held 1.92 Million
0 calls
0 puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 0.82%
# of Institutions 20

Quarterly Institutional Activity in NVTA

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding NVTA

View all
View all

Latest Institutional Activity in NVTA

Top Purchases

Q2 2024
Redwood Wealth Management Group, LLC Shares Held: 28.2K ($0)
28.2K Shares purchased
New Holding
Q2 2024
Mai Capital Management Shares Held: 10K ($0)
10K Shares purchased
New Holding
Q2 2024
Creative Financial Designs Inc Shares Held: 50 ($0)
50 Shares purchased
New Holding
Q2 2024
Ever Source Wealth Advisors, LLC Shares Held: 1.36K ($0)
43 Shares purchased
3.27% Added
Q1 2024
State Of Wyoming Shares Held: 3.65M ($0)
3.24M Shares purchased
781.24% Added
View All Buyers

Top Sells

Q2 2024
Glen Eagle Advisors, LLC Shares Held: 0 ($0)
300 Shares sold
Closed
Q2 2024
Strategic Blueprint, LLC Shares Held: 28K ($0)
300 Shares sold
1.06% Reduced
Q1 2024
Barclays PLC Shares Held: 37.2K ($0)
384K Shares sold
91.18% Reduced
Q1 2024
Goldman Sachs Group Inc Shares Held: 902K ($0)
172K Shares sold
15.99% Reduced
Q1 2024
Td Waterhouse Canada Inc. Shares Held: 0 ($0)
46K Shares sold
Closed
View All Sellers

About NVTA

Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.

NVTA Chart by TradingView
NVTA Fundamental Data by TradingView

Insider Transactions at NVTA

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
Dec 20 2023
Robert L Nussbaum Chief Medical Officer
SELL
Payment of exercise price or tax liability
Direct
17,404 -3.06%
$0 $0.65 P/Share
Dec 20 2023
Thomas Brida
SELL
Payment of exercise price or tax liability
Direct
17,404 -1.86%
$0 $0.65 P/Share
Nov 13 2023
David Sholehvar Chief Operating Officer
BUY
Grant, award, or other acquisition
Direct
850,000 +50.0%
-
Oct 18 2023
Thomas Brida
BUY
Grant, award, or other acquisition
Direct
229,500 +19.73%
-
Oct 02 2023
Ana J. Schrank Chief Financial Officer
BUY
Grant, award, or other acquisition
Direct
850,000 +50.0%
-
Sep 23 2023
Robert M. Guigley Chief Commercial Officer
BUY
Grant, award, or other acquisition
Direct
850,000 +50.0%
-
Jun 13 2023
Thomas Brida
SELL
Open market or private sale
Direct
7,079 -1.0%
$7,079 $1.38 P/Share
Jun 13 2023
Robert L Nussbaum Chief Medical Officer
SELL
Open market or private sale
Direct
7,086 -1.23%
$7,086 $1.38 P/Share
May 16 2023
Kenneth D. Knight Chief Executive Officer
SELL
Open market or private sale
Direct
45,432 -2.65%
$45,432 $1.2 P/Share
May 16 2023
Robert F. Werner Chief Accounting Officer
SELL
Open market or private sale
Direct
21,559 -5.73%
$21,559 $1.2 P/Share
May 16 2023
Robert L Nussbaum Chief Medical Officer
SELL
Open market or private sale
Direct
26,476 -4.39%
$26,476 $1.2 P/Share
May 16 2023
Thomas Brida
SELL
Open market or private sale
Direct
26,476 -3.59%
$26,476 $1.2 P/Share
Apr 27 2023
Randal W. Scott Director
BUY
Grant, award, or other acquisition
Direct
70,422 +30.4%
-
Apr 27 2023
Chitra Nayak Director
BUY
Grant, award, or other acquisition
Direct
70,422 +38.81%
-
Apr 27 2023
Eric Aguiar Director
BUY
Grant, award, or other acquisition
Direct
70,422 +35.98%
-
Apr 27 2023
Christine Marie Gorjanc Director
BUY
Grant, award, or other acquisition
Direct
70,422 +38.81%
-
Apr 27 2023
William H Osborne Director
BUY
Grant, award, or other acquisition
Direct
88,027 +21.67%
-
Apr 27 2023
Kimber D Lockhart Director
BUY
Grant, award, or other acquisition
Direct
70,422 +38.81%
-
Apr 27 2023
Geoffrey Crouse Director
BUY
Grant, award, or other acquisition
Direct
70,422 +35.09%
-
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on NVTA

Follow Invitae Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVTA shares.

Notify only if
Any

Insider Trading

Get notified when an Invitae Corp insider buys or sells NVTA shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Invitae Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NVTA